We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulat... Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. Show more
-- Accomplished Business and Financial Leader, Laura Brege, Appointed Chair -- -- Paul J. Hastings and Andreas Wicki, PhD Retire from Board of Directors -- PARSIPPANY, N.J., Jan. 30, 2025...
The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc. (PCRX) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Jan. 30, 2025 NEW YORK, Jan. 30, 2025...
Investors in Pacira BioSciences, Inc. Should Contact The Gross Law Firm Before March 14, 2025 to Discuss Your Rights - PCRX PR Newswire NEW YORK, Jan. 27, 2025 NEW YORK, Jan. 27, 2025...
Investors who lost money on Pacira BioSciences, Inc.(PCRX) should contact The Gross Law Firm about pending Class Action - PCRX PR Newswire NEW YORK, Jan. 23, 2025 NEW YORK, Jan. 23, 2025...
-- Brendan Teehan named Chief Commercial Officer and Krys Corbett named Chief Business Officer -- -- Key additions expected to support company’s 5x30 path to becoming an innovative...
Pacira BioSciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - PCRX PR Newswire NEW YORK, Jan. 20, 2025 NEW YORK, Jan. 20, 2025...
Pacira BioSciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before March 14, 2025 to Discuss Your Rights - PCRX PR Newswire NEW YORK, Jan. 16, 2025...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.55 | 15.1969178082 | 23.36 | 27.07 | 23.195 | 1161946 | 25.37256437 | CS |
4 | 7.668 | 39.8503274088 | 19.242 | 27.07 | 18.17 | 858829 | 22.24640096 | CS |
12 | 9.375 | 53.4644995723 | 17.535 | 27.07 | 16 | 792350 | 19.7101139 | CS |
26 | 6.57 | 32.3008849558 | 20.34 | 27.07 | 11.26 | 949345 | 16.61692654 | CS |
52 | -6.73 | -20.0059453032 | 33.64 | 34.01 | 11.26 | 878497 | 21.30648765 | CS |
156 | -34.49 | -56.1726384365 | 61.4 | 82.16 | 11.26 | 632501 | 34.77209737 | CS |
260 | -16.07 | -37.3894834807 | 42.98 | 82.16 | 11.26 | 586659 | 42.06142516 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions